NYSEArca - Delayed Quote USD

SPDR S&P Biotech ETF (XBI)

91.18 -1.41 (-1.52%)
At close: May 17 at 4:00 PM EDT
91.21 +0.03 (+0.03%)
After hours: May 17 at 7:58 PM EDT

Top 10 Holdings (12.90% of Total Assets)

SymbolCompany% Assets
ALPN
Alpine Immune Sciences, Inc. 1.88%
RVMD
Revolution Medicines, Inc. 1.32%
IBRX
ImmunityBio, Inc. 1.30%
VKTX
Viking Therapeutics, Inc. 1.26%
MRNA
Moderna, Inc. 1.22%
EXEL
Exelixis, Inc. 1.20%
NTRA
Natera, Inc. 1.19%
CRNX
Crinetics Pharmaceuticals, Inc. 1.18%
CERE
Cerevel Therapeutics Holdings, Inc. 1.18%
GERN
Geron Corporation 1.18%

Sector Weightings

SectorXBI
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Stocks 99.90%
Bonds 0.00%

Equity Holdings

Price/Earnings 0
Price/Book 0.27
Price/Sales 0.15
Price/Cashflow 0
Median Market Cap --
3 Year Earnings Growth --

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

ETF Summary

In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").

ETF Overview

Category Health
Fund Family SPDR State Street Global Advisors
Net Assets 6.36B
YTD Daily Total Return 2.12%
Yield 0.02%
Legal Type Exchange Traded Fund

Related Tickers